FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
122,342,805
Total 13F shares
25,410,496
Share change
-1,221,119
Total reported value
$100,632,735
Price per share
$3.96
Number of holders
71
Value change
-$4,500,070
Number of buys
34
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FRANKLIN RESOURCES INC
13F
Company
5%
6,076,879
$19,689,000 30 Jun 2017
13F
FMR LLC
13F
Company
3.6%
4,346,785
$14,084,000 30 Jun 2017
13F
EcoR1 Capital, LLC
13F
Company
2.1%
2,537,026
$8,220,000 30 Jun 2017
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
2%
2,473,186
$8,013,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
1.4%
1,658,727
$5,375,000 30 Jun 2017
13F
Redmile Group, LLC
13F
Company
1.2%
1,419,058
$4,598,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
1%
1,264,281
$4,096,000 30 Jun 2017
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.94%
1,150,947
$3,729,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.52%
633,944
$2,054,000 30 Jun 2017
13F
683 Capital Management, LLC
13F
Company
0.48%
588,237
$1,906,000 30 Jun 2017
13F
Casdin Capital, LLC
13F
Company
0.45%
550,000
$1,782,000 30 Jun 2017
13F
STATE STREET CORP
13F
Company
0.36%
443,462
$1,437,000 30 Jun 2017
13F
BVF INC/IL
13F
Company
0.32%
391,386
$1,268,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.3%
368,208
$1,193,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.25%
308,800
$1,001,000 30 Jun 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.21%
253,063
$820,000 30 Jun 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
250,000
$810,000 30 Jun 2017
13F
Telemetry Investments, L.L.C.
13F
Company
0.18%
225,700
$731,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
177,082
$573,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.13%
157,546
$511,000 30 Jun 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.09%
115,275
$373,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.09%
111,775
$362,000 30 Jun 2017
13F
ALGERT GLOBAL LLC
13F
Company
0.08%
102,169
$331,000 30 Jun 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.08%
93,583
$303,000 30 Jun 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.06%
71,990
$233,000 30 Jun 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
67,500
$219,000 30 Jun 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.05%
66,000
$214,000 30 Jun 2017
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.05%
63,500
$206,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
53,614
$174,000 30 Jun 2017
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.04%
50,004
$162,000 30 Jun 2017
13F
Neuberger Berman Group LLC
13F
Company
0.04%
49,700
$161,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.04%
43,851
$141,000 30 Jun 2017
13F
UBS Group AG
13F
Company
0.04%
43,625
$141,000 30 Jun 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
40,967
$133,000 30 Jun 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
40,500
$131,000 30 Jun 2017
13F
TFS CAPITAL LLC
13F
Company
0.03%
34,107
$111,000 30 Jun 2017
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.02%
30,000
$97,000 30 Jun 2017
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.02%
29,510
$96,000 30 Jun 2017
13F
Squarepoint Ops LLC
13F
Company
0.02%
28,900
$94,000 30 Jun 2017
13F
Creative Planning
13F
Company
0.02%
28,000
$91,000 30 Jun 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
23,650
$77,000 30 Jun 2017
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
23,500
$76,000 30 Jun 2017
13F
Nationwide Fund Advisors
13F
Company
0.02%
21,117
$68,000 30 Jun 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
21,010
$68,000 30 Jun 2017
13F
Invesco Ltd.
13F
Company
0.02%
20,736
$67,000 30 Jun 2017
13F
BARCLAYS PLC
13F
Company
0.01%
11,638
$38,000 30 Jun 2017
13F
STRS OHIO
13F
Company
0.01%
11,100
$35,000 30 Jun 2017
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.01%
10,300
$33,000 30 Jun 2017
13F
Community Bank, N.A.
13F
Company
0.01%
6,500
$21,000 30 Jun 2017
13F
Legal & General Group Plc
13F
Company
0%
5,627
$18,000 30 Jun 2017
13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2017

As of 30 Sep 2017, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,410,496 shares. The largest 10 holders included FRANKLIN RESOURCES INC, FMR LLC, Polaris Venture Management Co. V, L.L.C., EcoR1 Capital, LLC, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, MORGAN STANLEY, and Casdin Capital, LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
57
Q3 2017 holders
71
Holder diff
14
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .